Cellular Cardiomyoplasty For Myocardial Infarction: a 2014 Evidence-based Update

Authors

  • Alvin Nursalim Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
  • Puspita A Katili Master Program in Stem Cell Technology, Faculty of Medicine and Health Sciences, The University of Nottingham, United Kingdom
  • Teguh Santoso Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Abstract

Myocardial infarction is one of the main cause of mortality in many countries. Therefore, an effective therapy for myocardial infarction is required. Reperfusion and other conventional therapy have been the mainstay therapy for myocardial infarction. However, many patients remain refractory to this therapy. Cellular cardiomyoplasty is considered a novel therapy, in which stem cells are used for cardiac repair. Stem cells are potential therapeutic approach that could be the ultimate solution for salvaging damaged cardiomyocyte. Based on current studies, stem cells are a promising therapeutic approach for myocardial infarction. However, some challenges need to be answered by future studies before this novel therapy can be widely applied. As we advance our understanding, all questions behind stem cell therapy would finally be revealed, and eventually provide the ultimate solution for ischaemic cardiac repair. This paper provide an overview of the latest progress in stem cell therapy for myocardial infarction. Key words: stem cells, cellular cardiomyoplasty, myocardial infarction

Downloads

Published

2016-05-16

How to Cite

Nursalim, A., Katili, P. A., & Santoso, T. (2016). Cellular Cardiomyoplasty For Myocardial Infarction: a 2014 Evidence-based Update. Acta Medica Indonesiana, 46(2). Retrieved from https://actamedindones.org/index.php/ijim/article/view/83

Issue

Vol. 46 No. 2 (2014)

Section

SPECIAL ARTICLE

License

Copyright

The authors who publish in this journal agree to the following requirements:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.